Market-Moving News for October 14th
Market-Moving News for October 14th
10月14日的市場推動資訊
JSPR: 32% | Jasper Therapeutics shares are trading higher after the company announced it reported preliminary data from the Company's ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab in adult participants with cold urticaria or symptomatic dermographism.
JSPR:32% | Jasper Therapeutics股份上漲,因公司宣佈發佈了公司正在進行的SPOTLIGHt第1b/2a階段研究亞冰凝疹或有症狀皮膚筋膜炎成年參與者的初步數據。
LFVN: 11% | LifeVantage shares are trading higher after the company announced the US launch of its MindBody GLP-1 System.
LFVN:11% | lifevantage股份上漲,因公司宣佈美國推出其MindBody GLP-1系統。
IVA: 177% | Inventiva Raises Up To €348M To Fund Phase 3 NATiV3 Clinical Trial For MASH, Appoints New Chairman and Director
IVA:177% | inventiva籌集高達34800萬歐元用於基金第3期NATiV3臨床試驗MASH,任命新主席和董事。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。